Janux Therapeutics, Inc. (JANX) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($155.54M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11189693.00 | $155.54M | 2026-03-31 |
| BlackRock, Inc. | 5433233.00 | $75.52M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 4196409.00 | $58.28M | 2026-03-31 |
| Prosight Management, LP | 3550000.00 | $49.34M | 2026-03-31 |
| VANGUARD GROUP INC | 2906386.00 | $40.11M | 2025-12-31 |
| FMR LLC | 2535724.00 | $35.25M | 2026-03-31 |
| STATE STREET CORP | 2464017.00 | $34.25M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1811365.00 | $25.18M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 |
Back to JANX overview · JANX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.